Reprocessed Tissue Removal Suite
Our reprocessed hysteroscopic tissue removal devices are FDA 510(k) cleared, clinically equivalent to the OEM and supported by pre-market testing. The devices are intended for intrauterine use by trained gynecologists to hysteroscopically resect and remove tissue such as: submucous myomas, endometrial polyps and retained products of conception.